NEWS
View news from our Featured Companies.
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
CARMEL, Ind., Nov. 08, 2023 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced it has...
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Total of 20 Centers Currently Open with Approximately 40 Expected by End of 2023 in SHIELD II Phase 3 Trial Evaluating D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Completed Production and Release of Three Process Validation Batches of...
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
DENVER, CO / November 7, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report financial results for its first quarter of fiscal year 2024 for the period ended September...
Precision Optics Corporation Schedules First Quarter of Fiscal Year 2024 Conference Call for Tuesday, November 14, 2023
GARDNER, Mass., Nov. 7, 2023 -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
Conference Call Scheduled for Tuesday, November 14, 2023 at 9:00 AM ETPORTLAND, Maine, Nov. 07, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and...
InfuSystem Reports Third Quarter 2023 Financial Results
Record Net Revenues of $31.9 million Representing 17% Growth from the Prior Year Operating Income Increased 80% - Net Income Increased 56% - Adjusted EBITDA Increased 11% Raising Full Year 2023 Net Revenue Guidance ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc....
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
Biopharmaceutical Industry Veteran Nurit Tweezer-Zaks, M.D., M.B.A. Appointed to Board Following Retirement of Anat Tsour SegalPETACH TIKVA, Israel, Nov. 07, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to...
AAO Late-Breaking: Kiora’s Small Molecule Photoswitch Demonstrates Meaningful Vision Improvements in Blind Patients with Retinitis Pigmentosa
Topline Phase I/II First-in-Human Results Presented at AAO 2023Significant improvement in visual field, in concordance with trended improvements in visual acuity and functional visionFunctional MRI demonstrates increased brain activity in visual cortexNovel small...
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
Reports record revenue of $16.5 million for the third quarter of 2023.GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43.Third quarter operating income of $5.9 million, an increase of 43% compared to the same period in 2022. WINTER SPRINGS, Fla., Nov. 03,...
LiqTech International to Discuss Third Quarter 2023 Results on Thursday, November 9, 2023
Management to Host Conference Call on Thursday, November 9, 2023, at 10:00 a.m. ET BALLERUP, Denmark, Nov. 2, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and...
SenesTech to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
Financial results to be released after market close;Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 2, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2023, ended September 30, 2023, after the market close on...
S&W Seed Company to Report First Quarter Fiscal Year 2024 Financial Results on Thursday, November 9, 2023
Conference call to be conducted on Thursday, November 9, 2023, at 11:00AM ET LONGMONT, Colo., Nov. 2, 2023 -- S&W Seed Company (Nasdaq: SANW) will report financial results for its first quarter fiscal year 2024, ended September 30, 2023, on Thursday, November 9,...
LiqTech Enters Distribution Agreement with Waterco Across Australia and Asia Pacific for Swimming Pool Water Filtration System Market
BALLERUP, Denmark, Nov. 2, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced it has entered into an exclusive distribution agreement with...
SenesTech Taking Orders for Evolve™ Soft Bait for Rodent Fertility Control
The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. PHOENIX, Nov. 1, 2023 -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control to manage...
ChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg Featuring Niagen® (Patented Nicotinamide Riboside), One of the Most Efficient Nicotinamide Adenine Dinucleotide (NAD+) Boosters Available, to Consumers Nationwide
Tru Niagen® Pro 1,000mg is recommended by physicians and used by pro-athletes as it is clinically proven to boost NAD+ levels by up to 150% in as little as three weeks LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine...
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
PETACH TIKVA, Israel, Nov. 01, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2023 financial results and operational highlights...
Modular Medical Updates Test Progress and Submission Timeline
SAN DIEGO, CA / October 31, 2023 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today...
InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
ChromaDex to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) ("the Company") a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, November 8, 2023 at 4:30 p.m. ET to discuss its financial results for the third quarter,...
LiqTech Expands its Geographic Reach in Swimming Pool Water Filtration System Market
BALLERUP, Denmark, Oct. 30, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced it has entered a new agreement for the distribution of...
Mogo Comments on Recent Share Price Volatility
Mogo reaffirms its Financial Targets for FY 2023 Company has repurchased a total of 587,789 shares over the past 12 months (~2% of current shares outstanding) VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's...
Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
- Successfully met primary endpoint; brilaroxazine 50 mg delivered a statistically significant and clinically meaningful 10.1-point reduction in Positive and Negative Syndrome Scale (PANSS) total score vs. placebo at week 4, p<0.001 - - Statistically significant...
Mogo Schedules Q3 2023 Earnings Conference Call
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today announced it will hold a conference call and webcast to discuss its Q3 2023 financial results on Thursday, November...
Free Registration Is Now Open For Tribe Public’s CEO and Q&A Presentation Webinar Event “Accelerating Biotech Value Creation” Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023
An Introduction to NAYA Biosciences with CEO Dr. Daniel TeperManaging unprecedented medical innovation in an era of financial market volatilityIncreasing patient access to breakthrough treatments in oncology, regenerative medicine, and fertilitySARASOTA, Fla. and...
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
WINTER SPRINGS, Fla., Oct. 26, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 third quarter financial results before the market opens on Friday, November 3rd. IRADIMED management will host a conference call the same...